BALANCED CLINICAL RESEARCH SERVICES LIMITEDActive

Company number 05985649Private limited companyIncorporated 2006

Key figures

£22,349-17.6%
Net assets 2024/25
-6.5%
Average annual change 2019/20–2024/25
020 k40 k60 k80 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, BALANCED CLINICAL RESEARCH SERVICES LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
050 k100 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand—————
Total assets94,52244,76753,03643,61739,578
Total liabilities17,64416,47711,50314,99617,229
Net assets / total equity69,37822,79438,03727,12522,349
Average number of employees11100

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: BALANCED CLINICAL RESEARCH SERVICES LIMITED

Company

BALANCED CLINICAL RESEARCH SERVICES LIMITED is a private limited company registered with Companies House under company number 05985649. It was incorporated on 1 Nov 2006. Its status is active. The registered office is in United kingdom (PE29). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110), other professional, scientific and technical activities n.e.c. (74909).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Oct 2025); the company files micro-entity accounts. Net assets were £22,349, down 17.6% on the previous year. Total assets were £39,578 and total liabilities £17,229. The company had an average of 0 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 31 Jul 2027. The next confirmation statement is due by 18 Jan 2027.